Telomerase activity in B-cell non-Hodgkin lymphoma

Area of Science:

• Oncology
• Molecular Biology
• Hematology

Background:

• Telomerase activity is observed in some B-cell non-Hodgkin lymphomas (B-NHLs).
• Previous studies lacked systematic, quantitative assessment of telomerase in B-NHLs.
• The in vivo relationship between telomerase and proliferation in B-NHLs requires further investigation.

Purpose of the Study:

• To systematically quantify telomerase activity in various B-NHLs.
• To investigate the in vivo correlation between telomerase activity and proliferation index (PI) in B-NHLs.
• To assess the potential efficacy of antitelomerase drugs for B-NHLs.

Main Methods:

• Classified 111 B-NHLs and 18 benign biopsies using the REAL classification.
• Assayed all samples for telomerase activity.
• Determined the proliferation index (PI) for each B-NHL sample.

Main Results:

• Telomerase activity was detected in 96% of B-NHLs, excluding low-grade marginal zone B-cell lymphomas (MZBCLs).
• A significant correlation was found between telomerase activity and proliferation index (r=0.7536, P < 0.001).
• Telomerase activity was absent below a proliferation index of 9.2%.

Conclusions:

• Telomerase activity levels correlate with the clinical aggressiveness of B-NHL subtypes.
• Low-grade MZBCLs uniquely lack significant telomerase activity.
• The in vivo association between telomerase activity and PI suggests cell cycle control and supports the potential efficacy of antitelomerase therapies in most B-NHLs.